OBI Pharma CEO Wang Hui-chun Retires End of April, Stock Hits Limit Down Today
NQ Score
0/100
N1 Content Completeness
8
AI Summary (NQ-processed)
OBI Pharma announced the sudden retirement of CEO Wang Hui-chun on April 30. The unexpected news shocked the biotech sector, sending the stock limit down. The company assures R&D and operations remain unaffected.